Overview
Clinical Meaning
Conn syndrome (primary hyperaldosteronism) is excessive aldosterone production independent of the renin angiotensin system, most commonly from a unilateral aldosterone producing...
PMHNP
PMHNP
Conn syndrome (primary hyperaldosteronism) is excessive aldosterone production independent of the renin-angiotensin system, most commonly from a unilateral aldosterone-producing adenoma (35%) or bilateral adrenal hyperplasia (60%). Aldosterone acts on the mineralocorticoid receptor in the principal cells of the collecting duct, upregulating ENaC (epithelial sodium channel) and Na+/K+-ATPase, causing sodium reabsorption with potassium and hydrogen ion secretion. This produces: hypertension (volume expansion from sodium retention), hypokalemia (potassium wasting), and metabolic alkalosis (hydrogen ion secretion). The elevated aldosterone suppresses renin (via negative feedback from volume expansion), creating the characteristic LOW renin, HIGH aldosterone pattern. Primary hyperaldosteronism is far more common than previously recognized, affecting 5-10% of all hypertensive patients and up to 20% of those with resistant hypertension.
Unlock full lesson + practice questions
4 more sections with scenarios, priorities, and review drills.
Next study step
Finish the lesson first, then choose a focused activity to apply what you just reviewed.
Continue studying
Sign in to save progress on this lesson.
Unlock the interactive lesson quiz with a plan that includes this PMHNP pathway. You can still explore topic-filtered questions from the bank hubs below.